MedPath

Anatomy-Based Fitting in Unexperienced Cochlear Implant Users

Not Applicable
Recruiting
Conditions
Sensorineural Hearing Loss
Cochlear Implants
Interventions
Device: Default CI fitting
Device: Anatomy-based CI fitting
Registration Number
NCT05451628
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age ≥ 18 years
  • Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s)
  • Post-operative Computed Tomography (CT) scan of the CI electrode available
  • Pre-operative result of pure-tone audiometry, speech test in quiet and in noise available
  • Subject implanted with MED-EL cochlear implant(s)
  • Subjects received a Flex28, FlexSoft or Standard electrode
  • Subject planned to receive a SONNET 2 or RONDO 3 audio processor on the newly implanted side
  • Audio processor not yet activated on the newly implanted side
  • The most apical active electrode contact has to be inserted at least 450°
  • Minimum of 10 active channels can be activated
  • Fluent in the language of the test centre
  • Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure
Exclusion Criteria
  • Lack of compliance with any inclusion criteria
  • Electric Acoustic Stimulation (EAS) user (user of an EAS audio processor)
  • Implanted with C40+, C40X and C40C
  • Implanted with an Auditory Brainstem Implant (ABI) or Split electrode array
  • Anything that, in the opinion of the Investigator, would place the subject at increased risk or pre-clude the subject's full compliance with or completion of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Default CI fittingDefault CI fittingProgramming of cochlear implant speech processor according to standard clinical care
Anatomy-based CI fittingAnatomy-based CI fittingProgramming of cochlear implant speech processor with anatomy-based fitting
Primary Outcome Measures
NameTimeMethod
Speech recognition test in quiet (S0): percentage correctly identified phonemes6 months post-activation
Secondary Outcome Measures
NameTimeMethod
Result of the pitch matching test: frequency differences in semitones6 months post-activation
Result of the perception of timbre test: Score on Visual Analog Scale (VAS)6 months post-activation

Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.

Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure6 months post-activation
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit6 months post-activation
Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR6 months post-activation
Result of the pitch matching test: frequency difference in semitones3 months post-activation
Result of the speech contrast discrimination test: Psychometric function of phoneme categorization6 months post-activation
Datalogging data: Average numbers of hours per day6 months post-activation

Trial Locations

Locations (1)

UZ Brussel

🇧🇪

Brussel, Belgium

© Copyright 2025. All Rights Reserved by MedPath